Warfarin dose requirement in Turkish patients: the influences of patient characteristics and polymorphisms in CYP2C9, VKORC1 and factor VII Posted on March 4, 2019July 26, 2022 by admin ORIGINAL ARTICLE Hippokratia 2014, 18(4):319-327 Yildirim E, Erol K, Birdane A Pharmacology Department, Cardiology Department Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey
Be careful before prescribing warfarin and octreotide together: a new drug-drug interaction report Posted on March 4, 2019July 26, 2022 by admin LETTER Hippokratia 2014, 18(4):377 Yılmaz B, Kemal Y,Teker F Department of Medical Oncology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
Warfarin maintenance dose associated with genetic polymorphisms of CYP2C9 Posted on March 4, 2019July 21, 2022 by admin RESEARCH ARTICLE Hippokratia 2017, 21(2):93-96 Khaleqsefat E, Khalaj-Kondori M, Jabbarpour Bonyadi M, Battaloğlu E Department of Animal Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran, Department of Molecular Biology and Genetics, Boğaziçi University, Istanbul, Turkey